Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Current Opinion in Infectious Diseases|October 24, 2024
Antiviral combination treatment strategies for SARS-CoV-2 infection in immunocompromised patientsChiara Sepulcri, Claudia Bartalucci, Malgorzata Mikulska
Current Opinion in Critical Care|September 5, 2025
Optimal duration of antifungal therapy in candidemiaClaudia Bartalucci, Antonio Vena, Matteo Bassetti
Blood Reviews|April 29, 2023
Does PTCY increase the risk of infections?Malgorzata Mikulska, Claudia Bartalucci, Anna Maria Raiola, et al.
Future Microbiology|August 12, 2025
Clinical impact of fluconazole-resistant <i>Candida parapsilosis</i>: a narrative reviewClaudia Bartalucci, Antonio Vena, Daniele Roberto Giacobbe, et al.
The New Microbiologica|May 2, 2025
Two-drug regimen with dolutegravir plus lamivudine for HIV treatment in children: a narrative reviewClaudia Bartalucci, Laura Labate, Lucia Taramasso, et al.
Expert Opinion on Pharmacotherapy|October 13, 2025
Investigating cefepime/taniborbactam for the treatment of complicated urinary tract infectionsClaudia Bartalucci, Marianna Giurco, Antonio Vena, et al.
Expert Review of Anti-Infective Therapy|November 26, 2025
Advances and updates in antibiotic combination therapyClaudia Bartalucci, Chiara Sepulcri, Federica Portunato, et al.
European Journal of Clinical Investigation|January 22, 2026
Antifungal treatment strategies in intensive care unit patientsClaudia Bartalucci, Laura Mezzogori, Riccardo Schiavoni, et al.
Expert Opinion on Drug Metabolism & Toxicology|November 18, 2024
Rezafungin acetate for the treatment of candidemia and invasive candidiasis: a pharmacokinetic evaluationMatteo Bassetti, Adam Stewart, Claudia Bartalucci, et al.
The New Microbiologica|May 3, 2024
Lamivudine plus dolutegravir as a switch strategy in children: three case reportsLaura Labate, Claudia Bartalucci, Lucia Taramasso, et al.
Pageof 3